Found: 7
Select item for more details and to access through your institution.
MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib.
- Published in:
- British Journal of Cancer, 2017, v. 116, n. 6, p. 742, doi. 10.1038/bjc.2017.23
- By:
- Publication type:
- Article
MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Oncological patients' reactions to COVID‐19 pandemic: A single institution prospective study.
- Published in:
- Cancer Reports, 2022, v. 5, n. 10, p. 1, doi. 10.1002/cnr2.1571
- By:
- Publication type:
- Article
A Case Study of Clinical Response to Rucaparib in a Patient with Metastatic Castration-Resistant Prostate Cancer and a RAD51B Alteration.
- Published in:
- Current Oncology, 2022, v. 29, n. 6, p. 4178, doi. 10.3390/curroncol29060333
- By:
- Publication type:
- Article
Authors’ reply.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Triple-negative breast cancer: treatment challenges and solutions.
- Published in:
- Breast Cancer: Targets & Therapy, 2016, v. 8, p. 93, doi. 10.2147/BCTT.S69488
- By:
- Publication type:
- Article
Guidelines for the automated evaluation of Elispot assays
- Published in:
- Nature Protocols, 2015, v. 10, n. 7, p. 1098, doi. 10.1038/nprot.2015.068
- By:
- Publication type:
- Article